Systematic review, network meta-analysis and economic evaluation of biological therapy for the management of active psoriatic arthritis.
about
Economic impact of biologic utilization patterns in patients with psoriatic arthritisEconomic Evaluation of Timely Versus Delayed Use of Tumor Necrosis Factor Inhibitors for Treatment of Psoriatic Arthritis in the US.Pharmacoeconomic burden in the treatment of psoriatic arthritis: from systematic reviews to real clinical practice studies.Proteomics focusing on immune markers in psoriatic arthritis.EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis.Comparative Risk of Harm Associated With the Use of Targeted Immunomodulators: A Systematic Review.The use of adalimumab, etanercept, golimumab and infliximab in rheumatic pathologies: variation between label dosage and real-world use.Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults.Risk of tuberculosis comparison in new users of antitumour necrosis factor-α and with existing disease-modifying antirheumatic drug therapy.Cost-effectiveness analysis of secukinumab for the treatment of active psoriatic arthritis: a Canadian perspective.Cost-efficacy of biologic therapies for psoriatic arthritis from the perspective of the Taiwanese healthcare system.Assessing the effectiveness of synthetic and biologic disease-modifying antirheumatic drugs in psoriatic arthritis - a systematic review.Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK.
P2860
Q33840422-83F39DFC-57F1-46C9-B935-08F1CBB2B199Q37453027-5ABF610F-518C-474F-A255-0B8D1B78087CQ37515034-16210C18-993E-489B-9BBD-4058F2950C72Q38230695-27620043-5FFD-4402-A12A-23D0A3798C68Q38636348-8AA73376-72E6-4122-B4D1-FD3C9A80ADB3Q38668352-F947A795-11A5-49B3-86D0-D6605FC71032Q40942139-E2BB53A2-DAE3-45BC-9CD7-8B0E9910572AQ47093829-76BFB461-0065-4F2D-A17B-A89484256EC7Q47717769-227A0CE8-41F1-4AB0-BFB0-C746A5D285FFQ49850238-C3D1E6DF-8B37-4CD3-8DFA-EDF8FE59CE95Q51289760-E4C135BE-5A3A-4D08-8ED3-AA0EF672B4B5Q55109332-FF927DF4-3677-4299-B354-C96D1CA8E56AQ55452701-DB820342-C9FD-45D4-849F-0F2D6CF6DF67
P2860
Systematic review, network meta-analysis and economic evaluation of biological therapy for the management of active psoriatic arthritis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systematic review, network met ...... of active psoriatic arthritis.
@en
Systematic review, network met ...... of active psoriatic arthritis.
@nl
type
label
Systematic review, network met ...... of active psoriatic arthritis.
@en
Systematic review, network met ...... of active psoriatic arthritis.
@nl
prefLabel
Systematic review, network met ...... of active psoriatic arthritis.
@en
Systematic review, network met ...... of active psoriatic arthritis.
@nl
P2093
P2860
P356
P1476
Systematic review, network met ...... of active psoriatic arthritis
@en
P2093
Chris Knight
Dean Spurden
Henry Wildey
Michelle Elaine Orme
Stephen Andrew Mitchell
P2860
P2888
P356
10.1186/1471-2474-15-26
P5008
P577
2014-01-20T00:00:00Z
P5875
P6179
1011167965